FARALLON CAPITAL MANAGEMENT LLC - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$232,000
-95.5%
2,000
-97.3%
0.00%
-95.2%
Q2 2021$5,100,000
-89.4%
75,000
-88.0%
0.02%
-91.2%
Q1 2021$48,150,000
+52.9%
625,000
+19.0%
0.24%
+26.5%
Q4 2020$31,500,000
+54.0%
525,000
+10.5%
0.19%
+34.0%
Q3 2020$20,449,000
+9.7%
475,000
+5.6%
0.14%
-5.4%
Q2 2020$18,639,000
+72.4%
450,000
+80.0%
0.15%
+60.2%
Q1 2020$10,810,000250,0000.09%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 895,000$53,700,0004.14%
S Squared Technology, LLC 85,215$5,113,0002.93%
First Light Asset Management, LLC 491,740$29,504,0002.18%
Redmile Group, LLC 1,675,036$100,502,0001.22%
Nicholas Investment Partners, LP 233,543$14,013,0001.08%
HighMark Wealth Management LLC 17,586$1,055,0000.91%
DSAM Partners (London) Ltd 87,608$5,256,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 101,044$6,063,0000.54%
Hood River Capital Management LLC 261,122$15,667,0000.52%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 9,900$594,0000.45%
View complete list of KRYSTAL BIOTECH INC shareholders